The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era
A Mocroft, H J Furrer, J M Miro, P Reiss, C Mussini, O Kirk, S Abgrall, S Ayayi, B Bartmeyer, D Braun, A Castagna, A d'Arminio Monforte, B Gazzard, F Gutierrez, I Hurtado, Karina Jansen, L Meyer, P Muñoz, N Obel, P Soler-PalacinA Papadopoulos, F Raffi, J T Ramos, J K Rockstroh, D Salmon, C Torti, J Warszawski, S de Wit, R Zangerle, C Fabre-Colin, J Kjaer, G Chene, J Grarup, J D Lundgren, Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
Dive into the research topics of 'The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era'. Together they form a unique fingerprint.